PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsAzurity
Azurity
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
BidilHydralazine, Isosorbide2005-06-23
EdarbiAzilsartan kamedoxomil2011-02-252025-2031
EdarbyclorAzilsartan kamedoxomil, Chlorthalidone2011-12-202025-2031
EpanedEnalapril2013-08-132032-2036
EprontiaTopiramate2021-11-052027-2040
ErypedErythromycin ethylsuccinate1982-01-01
EvekeoAmphetamine2012-08-092024-2038
FirvanqVancomycin2018-01-262035
FleqsuvyBaclofen2022-02-042037-2041
GliadelCarmustine1996-09-23
HorizantGabapentin enacarbil2011-04-062025-2029
KaterziaAmlodipine benzoate2019-07-082029-2041
1
2
3
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Zonisamide
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use